By upregulating pro-inflammatory cytokines, anti-apoptotic protein Bcl-2, and angiogenesis-related VEGFR2, TLR7 activation in lung cancer increases tumor cell survival and resistance to apoptosis [66]. This evidence concerns the gene BCL2 and lung cancer.